急性一氧化碳中毒后不良神经认知结局预测评分(COGAS)的推导与验证
该预后研究基于韩国两家大学医院前瞻性连续收集的急性CO中毒患者数据,推导队列1016例、验证队列266例,年龄≥16岁。以中毒后4周全球衰退量表(GDS)4-7分定义为不良神经认知结局,推导队列发生率为12.4%。最终模型纳入年龄>50岁、GCS≤12分、休克、急诊就诊时血清肌酸激酶>320 U/L、未使用高压氧治疗5个变量,各计1分,构成COGAS评分。推导队列AUC 0.862(95%CI 0.828-0.895),验证队列AUC 0.870(95%CI 0.779-0.961)。作者认为,在CO中毒早期评估COGAS评分可能有助于识别不良神经认知后遗症高风险患者。
要点
- COGAS评分共5项,每项1分:年龄>50岁、GCS≤12分、休克、急诊就诊时血清肌酸激酶>320 U/L、未使用高压氧治疗。
- 推导队列1016例中126例(12.4%)出现不良GDS评分(4-7分);验证队列266例。
- 推导队列AUC 0.862(95%CI 0.828-0.895),验证队列AUC 0.870(95%CI 0.779-0.961)。
- 推导队列中879例有1年随访数据:757例(86.1%)GDS评分不变,102例(11.6%)改善,20例(2.3%)恶化。
- 作者认为,在CO中毒早期评估COGAS评分可能有助于识别不良神经认知后遗症高风险患者。
适用人群与场景
- 年龄16岁及以上、因急性一氧化碳中毒住院的患者。
- 数据来自韩国原州大学医院(2006年1月至2021年7月)和仁川大学医院(2016年8月至2020年6月)前瞻性连续收集的住院患者。
诊断标准与关键阈值
- 不良神经认知结局定义:一氧化碳暴露后1个月采用全球衰退量表(GDS)评估,4-7分为不良,1-3分为良好。
- COGAS评分项目及界值:年龄>50岁(1分)、GCS≤12分(1分)、休克(1分)、急诊就诊时血清肌酸激酶>320 U/L(1分)、未使用高压氧治疗(1分)。
研究设计与关键结果
- 研究类型:预后研究,包含推导队列和验证队列;总样本1282例,中位年龄47.0岁(IQR 35.0-59.0),男性810例(63.2%);推导队列1016例,验证队列266例。
- 推导队列中126例(12.4%)GDS评分为不良(4-7分)。
- 推导队列中有1年随访数据的879例:757例(86.1%)GDS评分不变,102例(11.6%)改善,20例(2.3%)恶化。
- 最终预测模型包含年龄>50岁、GCS≤12分、休克、急诊就诊时血清肌酸激酶>320 U/L、未使用高压氧治疗5个因素,各计1分,命名为COGAS评分。
- COGAS评分预测不良神经认知结局的AUC:推导队列0.862(95%CI 0.828-0.895),验证队列0.870(95%CI 0.779-0.961)。
证据类型、等级与局限
- 证据类型:预后研究(推导与验证队列),基于前瞻性连续收集的数据。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在急性一氧化碳中毒早期评估COGAS评分可能有助于识别不良神经认知后遗症高风险患者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Preventing neurocognitive sequelae is a major goal of treating acute carbon monoxide (co) poisoning. There is a lack of reliable score systems exist for assessing the probability of these sequelae.
OBJECTIVE: To develop and validate a novel clinical scoring system for predicting poor neurocognitive outcomes after acute co poisoning.
DESIGN, SETTING, AND PARTICIPANTS: This prognostic study included derivation and validation cohorts based on consecutive patient data prospectively collected at university hospitals from January 2006 to July 2021 in Wonju, Republic of Korea, and from August 2016 to June 2020 in Incheon, Republic of Korea. Participants included individuals aged 16 years or older admitted with co poisoning. Data were analyzed from October 2021 to January 2022.
EXPOSURES: Clinical and laboratory variables.
MAIN OUTCOMES AND MEASURES: The outcome of interest was neurocognitive sequelae at 4 weeks after co poisoning. Logistic regression models were used to identify predictors of poor neurocognitive outcomes in the derivation cohort. Outcomes were assessed using the Global Deterioration Scale [GDS] at 1-month after co exposure and classified as good (1-3 points) or poor (4-7 points).
RESULTS: A total of 1282 patients (median [IQR] age, 47.0 [35.0-59.0] years; 810 [63.2%] men) were assessed, including 1016 patients in the derivation cohort and 266 patients in the validation cohort. The derivation cohort included 126 patients (12.4%) with poor GDS scores. Among 879 patients in the derivation cohort with 1-year follow-up data, 757 (86.1%) had unchanged GDS scores, 102 (11.6%) had improved GDS scores, and 20 (2.3%) had worsened GDS scores. In the final prediction model, age older than 50 years (1 point), Glasgow Coma Scale score of 12 or less (1 point), shock (1 point), serum creatine kinase level greater than 320 U/L at emergency department presentation (1 point), and no use of hyperbaric oxygen therapy (1 point) remained factors significantly associated with worse outcome; therefore, this scoring system was called COGAS (creatine kinase, hyperbaric oxygen therapy, Glasgow Coma Scale, age, shock). Area under the receiver operating characteristic curve for COGAS score was 0.862 (95% CI, 0.828-0.895) for the derivation cohort and 0.870 (95% CI, 0.779-0.961) for the validation cohort.
CONCLUSIONS AND RELEVANCE: These findings suggest that assessing the COGAS score during the early phase of co poisoning may help identify patients at risk of poor neurocognitive sequelae.
参考来源
- Kim SH, Lee Y, Kang S, et al. Derivation and Validation of a Score for Predicting Poor Neurocognitive Outcomes in Acute Carbon Monoxide Poisoning. JAMA Netw Open. 2022. PMID: 35511176. doi:10.1001/jamanetworkopen.2022.10552
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。